Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.44 |
| ▸ | GLRB | P48167 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 8/20 | 0.40 |
| ▸ | AKR1C2 | P52895 | 8/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GALR3 | O60755 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL283603 | 1.00 | CYP1A2 (0.50) | CYP1A2CYP2C9CYP2C19GLRA3GLRB | |
| SCHEMBL29408356 | 1.00 | CYP1A2 (0.50) | CYP1A2CYP2C9CYP2C19GLRA3GLRB | |
| SCHEMBL38652043 | 0.98 | CYP1A2 (0.49) | CYP1A2CYP2C9CYP2C19GLRA3GLRB | |
| SCHEMBL27505107 | 0.93 | CYP1A2 (0.44) | CYP1A2CYP2C9CYP2C19GLRA3GLRB | |
| SCHEMBL11704980 | 0.90 | CYP2C9 (0.50) | CYP1A2CYP2C9CYP2C19GLRA3GLRB | |
| SCHEMBL100584 | 0.90 | GLRA3 (0.50) | CYP1A2GLRA3GLRBSMN1; SMN2CA2 | |
| SCHEMBL6275312 | 0.90 | GLRA3 (0.50) | CYP1A2GLRA3GLRBSMN1; SMN2CA2 | |
| Methane SCHEMBL4556718 | 0.88 | GLRA3 (0.48) | CYP1A2GLRA3GLRBSMN1; SMN2CA2 | |
| Hydrochloric Acid SCHEMBL1874072 | 0.88 | GLRA3 (0.48) | CYP1A2GLRA3GLRBSMN1; SMN2CA2 | |
| SCHEMBL38652274 | 0.88 | GLRA3 (0.48) | CYP1A2GLRA3GLRBSMN1; SMN2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030146412-A1 | Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers | CYTEC TECHNOLOGY CORP. | 2003-08-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030146412-A1 | Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers | CRYZ, AHR, ERCC4 | CYP1A2 111/4885CYP2C9 1113/4885CYP2C19 1043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.